Skip to content
Screener

uniQure QURE Interest Income

Interest Income at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$6.21M+18.1%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$2.59M+95.0%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$2.07M-23.4%
Candel Therapeutics, Inc. logo
Candel Therapeutics, Inc.CADL
$1.32M+41.5%
Regenxbio logo
RegenxbioRGNX
$1.22M-63.8%
Arvinas logo
ArvinasARVN
$6.4M-45.3%

Segments

By segment

See full
Single Reportable$5.05M+43.3%

Other financials

Income statement

See full
Revenue$5.8M+11.0%
Gross profit$5.5M+19.2%
Operating income-$52.2M-19.0%
Net income-$81.1M-115%
EPS (diluted)-$1.22-76.8%

Balance sheet

See full
Cash & equivalents$413.0M+62.8%
Total debt$62.8M-5.8%
Total equity$324.1M+8,195%
Total assets$985.1M+68.4%

Cash flow

See full
Operating cash flow-$28.6M+28.4%
CapEx$472.0K+81.5%
Free cash flow-$29.0M+27.7%

Valuation

See full
Market cap$3.15B+325%
Enterprise value$2.8B+406%
P/S168.5×+117×

Profitability

See full
Gross margin92.5%+4.6pp
Operating margin-1,071.5%-90.6pp
Net margin-1,350.7%-35.3pp
FCF margin-864.7%-194pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.2×
Current ratio10×0.0×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: uniQure’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 7:17 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-087815
Line itemThree months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Other income1,5982,5973,23010,903
Other expense(7,961)(2,185)(9,412)(4,144)
Loss from operations(52,203)(43,865)(97,923)(83,196)
Interest income5,0513,52410,2807,651
Interest expense(14,366)(15,591)(28,397)(30,700)
Foreign currency (losses) / gains, net(1,730)18,638(4,024)25,810
Other non-operating (losses), net(15,970)(12,201)
Loss before income tax expense$(79,218)$(37,294)$(132,265)$(80,435)

Item 1.Financial Statements

FAQ

What is uniQure's interest income?
uniQure (QURE) reported interest income of $5.05M in Q2 2026.
How has uniQure's interest income changed year-over-year?
uniQure's interest income increased by 43.3% year-over-year, from $3.52M to $5.05M.
What is the long-term trend for uniQure's interest income?
Over 4 years (2021 to 2025), uniQure's interest income has grown at a 219.9% compound annual growth rate (CAGR), from $162K to $16.97M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about uniQure's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude